Status:
TERMINATED
Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Infertility
Eligibility:
FEMALE
18-35 years
Phase:
NA
Brief Summary
The objective is to evaluate the influence of chemotherapy, either for auto-immune disease, either for carcinologic disease, on clinical and biological markers of ovarian reserve, for young patients, ...
Detailed Description
The study will enrol patients between 18 and 35 years, treated with neoadjuvant or adjuvant chemotherapy for systemic lupus erythematosus (Group 1), breast cancer (Group 2) or Hodgkin disease (Group 3...
Eligibility Criteria
Inclusion
- Women volunteers treated by chemotherapy,
- ≥ 18 and ≤ 35 years old
- Regular menstrual cyclicity, between 25 and 35 days
- Social security affiliation
- Signed informed consent
Exclusion
- Women \< 18 and \> 35 years old
- Pregnancy
- Emergent treatment necessity
- No social security affiliation
- Virgin patients
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00712452
Start Date
June 1 2008
End Date
June 1 2009
Last Update
May 14 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AP-HP Hôpital Antoine Béclère
Clamart, France, 92141